Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

BACKGROUND: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown. METHODS: An observational study was carried out on the Italian MASTER...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Postorino, Maria Concetta, Prosperi, Mattia, Focà, Emanuele, Quiros-Roldan, Eugenia, Di Filippo, Elisa, Maggiolo, Franco, Borghetti, Alberto, Ladisa, Nicoletta, Di Pietro, Massimo, Gori, Andrea, Sighinolfi, Laura, Pan, Angelo, Mazzini, Nicola, Torti, Carlo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://ncbi.nlm.nih.gov/pubmed/28298195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2322-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars